Search clinical trials for: diabetes type II

Total 94359 results

Bayer

Completed

Phase IIb Safety and Efficacy Study of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Disease Alone (ARTS-HF Japan)

Heart Failure

Japan
GlaxoSmithKline

Completed

Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis

Gastroparesis

United States, Australia, Belgium, United Kingdom, Canada, Sweden
Tris Pharma, Inc.

Completed

Painful Diabetic Polyneuropathy Trial With a New Centrally Acting Analgesic

Diabetic Polyneuropathy

Germany, United Kingdom
Medical College of Wisconsin
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Telephone Delivered Behavioral Skills Intervention for Blacks With T2DM (DM-TBSI)

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin Dependent

United States
Universität des Saarlandes

Completed

Pegfilgrastim and Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Aggressive B-Cell Non-Hodgkin Lymphoma

Lymphoma
Bayer

Completed

Phase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Chronic Kidney Disease Alone (ARTS-HF)

Heart Failure

France, Taiwan, United States, Turkey, Spain, Greece, Portugal, Germany, Canada, Austria, Czechia, Denmark, Israel, Korea, Republic of, Poland, South Africa, Sweden, Bulgaria, Italy, Finland, Hungary, Lithuania, Netherlands, Australia, ...
Laboratorios Silanes S.A. de C.V.

Suspended

Efficacy and Safety of Metformin Glycinate Compared to Metformin Hydrochloride on the Progression of Type 2 Diabetes (COMETII)

Type 2 Diabetes

Mexico
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

A Study of DBPR108 and Metformin Hydrochloride Combination Therapy in Patients With T2DM

Type 2 Diabetes Mellitus

China
Centre of Clinical Pharmacology, Hanoi Medical...

Completed

Evaluating Safety of Andiabet on Diabetes Mellitus Type II Patients, Phase I CT.

Diabetes Mellitus, Type 2

Vietnam
Universiti Sains Malaysia

Completed

Efficacy of Multigrain Supplementation in Type II Diabetes Mellitus

Type2 Diabetes

Malaysia
Kinderkrankenhaus auf der Bult

Completed

Pediatric Population Screening for Type 1 Diabetes and Familial Hypercholesterolemia in Lower Saxony, Germany (Fr1dolin)

Type 1 Diabetes | Familial Hypercholesterolemia
Relypsa, Inc.

Completed

Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN) (AMETHYST-DN)

Hypertension | Chronic Kidney Disease | Hyperkalemia

Croatia, Georgia, Hungary, Serbia, Slovenia
Basque Culinary Center Fundazioa
University of Navarra

Completed

HOME COOKING: Health Empowerment Strategy in People With Type II Diabetes Mellitus (SUKALMENA)

Type 2 Diabetes Mellitus

Spain
Hospital Alemão Oswaldo Cruz
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Clinical Study on Metabolic Surgery Compared to the Best Clinical Treatment in Patients With Type 2 Diabetes Mellitus (MOMS)

Complications of Diabetes Mellitus

Brazil
Theracos

Completed

Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

Type 2 Diabetes Mellitus

Germany, United States, Spain, Poland
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Pembrolizumab and Doxorubicin Hydrochloride in Treating Patients With Sarcoma That is Metastatic or Cannot Be Removed by Surgery

Sarcoma

United States
Stanford University
ConvaTec Inc.

Completed

Longevity of Multi-Slitted Catheter With Lantern Technology (Lantern)

Insulin Dependent Diabetes Mellitus 1

United States
German High-Grade Non-Hodgkin's Lymphoma Study...

Completed

Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma

Lymphoma

Switzerland, Germany, Italy, Netherlands, Poland, Sweden, United Kingdom, France, Czechia
University of Copenhagen
Hvidovre University Hospital

Completed

Effect of Neprilysin on Glucagon-Like Peptide-1 in Patients With Type 2 Diabetes (NEPT2D)

Type2 Diabetes

Denmark
Richmond Research Institute
Richmond Pharmacology Limited

Completed

Effect of Glucose on QTc Interval in Type 1 Diabetes

Diabetes

United Kingdom
QualiCCare
Novo Nordisk A/S; Sanofi; Swiss Society of Endocrinology and Diabetology; Roche... and other collaborators

Completed

Best Practice Study of Diabetes Type 2 Management in Primary Care in Switzerland

Diabetes Mellitus, Type 2 | Primary Care

Switzerland
Beacon Health System
Beacon Health Foundation; Coach Me Health

Active, not recruiting

Pilot of Virtual Health Coaching Utilizing Lifestyle for Under-Resourced Patients With Type II Diabetes

Type2 Diabetes

United States
Benno Brinkhaus
Karl and Veronica Carstens Foundation

Completed

ACUpuncture in Diabetic Peripheral Neuropathy (ACUDPN)

Diabetic Neuropathy

Germany
Magda Bayoumi

Completed

SOKARY Mobile Application With Type II Diabetes (DM)

Type II Diabetes

Egypt
Elpen Pharmaceutical Co. Inc.

Completed

Multiple Electrode Aggregometry & Clopidogrel Resistance

Coronary Artery Disease (CAD) | Type 2 Diabetes Mellitus (T2DM) | Myocardial Infraction

Greece
Novo Nordisk A/S

Completed

A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic Drugs (DUAL™ II Japan)

Diabetes Mellitus, Type 2 | Diabetes

Japan
Laboratorios Silanes S.A. de C.V.

Withdrawn

Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2 (DMMETCOV19)

Metabolic Syndrome | Type 2 Diabetes | Severe Acute Respiratory Syndrome Coronavirus 2

Mexico
Vedic Lifesciences Pvt. Ltd.

Completed

To Assess the Efficacy of Investigational Product on the Neuropathic Pain in Individuals Suffering From Type II Diabetes Mellitus.

Diabetic Neuropathies | Insomnia Due to Medical Condition

India
The Hashemite University

Completed

Intraoperative Insulin Administration at Cardiac Surgery for Diabetic Patients

Diabetes Mellitus | Cardiac Event

Jordan
Johnny Ludvigsson
Ostergotland County Council, Sweden; Diamyd Medical AB; Swedish Child Diabetes...

Completed

EDCR Study - Etanercept Diamyd Combination Regimen -Open Trial to Evaluate Safety in Children With Type 1 Diabetes

Diabetes Mellitus, Type 1

Sweden
National Institute of Diabetes and Digestive and...

Completed

Renoprotection in Early Diabetic Nephropathy in Pima Indians

Diabetic Nephropathy

United States
Cairo University
Kasr El Aini Hospital

Completed

Effect of Exercise on Cardiometabolic Risk Factors in Type II Diabetic Patients

Diabetes Mellitus, Type 2

Egypt
Medical University of Graz

Completed

Multifactorial Treatment of Cardiovascular Risk in Diabetic Patients: Identification of Treatment Non-Responders (CARDIONOR)

Diabetes Mellitus, Type II

Austria
German High-Grade Non-Hodgkin's Lymphoma Study...

Completed

Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma

Lymphoma

Germany, Israel, Italy
Mountain Diabetes and Endocrine Center

Completed

Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics

Diabetes Mellitus, Type II

United States
Federico II University

Completed

Polyphenol Enriched Extra-virgin Olive Oil and Postprandial Glycemia in Type 1 Diabetes (DOP) (DOP)

Type 1 Diabetes

Italy
InovoBiologic Inc.

Terminated

A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics

Obesity | Type II Diabetes Mellitus

Canada
Izmir Bakircay University
Muğla Sıtkı Koçman University; Cigli Regional Training Hospital

Unknown

Blood Sample Measurements and Physical Activity Levels in Type II Diabetes and/or COVID-19

Diabetes Mellitus, Type 2 | Covid19

Turkey
Hospital General Universitario Gregorio Marañon
Instituto de Salud Carlos III; University of Navarra; Fundación para la Investigación...

Unknown

Effects of SGLT2 Inhibition on the Mechanisms of Cardiac Damage in the Diabetic Patient With HFpEF (CARDIA-STIFF)

Diabetes Mellitus, Type 2 | Heart Failure With Preserved Ejection Fraction

Spain
GWT-TUD GmbH
Vifor Pharma

Completed

Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients With Iron Deficiency (CLEVER)

Type 2 Diabetes Mellitus | Iron Deficiency

Germany
Central European Society for Anticancer Drug Research

Unknown

Study in Patients With SCLC of Veliparib in Combination With Topotecan

Small Cell Lung Cancer SCLC

Germany
Taipei Medical University WanFang Hospital
Hi-Q Marine Biotech International, Ltd.

Unknown

Supplementation of Brown Seaweed on Insulin Resistance of NAFLD Patients With Pre- or Type 2-Diabetes

Type II Diabetes

Taiwan
Nantou Christian Hospital

Completed

Effect of Adding Renin-Angiotensin System Inhibitors to Standard Antidiabetic Therapy on Glycemic Control in Patients With Type 2 Diabetes Ellitus

Diabetes Mellitus, Type 2

Taiwan
Eli Lilly and Company

Completed

A Study of an Insulin Management System in Participants With Type 1 or Type 2 Diabetes

Type 1 Diabetes | Type 2 Diabetes

United States
Damanhour University
Tanta University

Completed

Type 2 Diabetic Patients Maintained on Statin Therapy

Dyslipidemia Associated With Type II Diabetes Mellitus

Egypt
Sanofi
Regeneron Pharmaceuticals

Completed

An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia

Hypercholesterolemia

Slovenia, Taiwan, Russian Federation, Canada, Netherlands, Brazil, Denmark, Mexico, Spain, Turkey
Novartis Pharmaceuticals

Completed

Efficacy and Long-Term Safety of Vildagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

Korea, Republic of, Latvia, Peru, Lithuania, Israel, Norway, Finland, Argentina, Austria, Belgium, Germany, Greece, Guatemala, Hungary, India, Italy, Mexico, Poland, Romania, Slovakia, Venezuela
National Taiwan University Hospital

Completed

Effects of Exercise Intervention and Confounding Factors on Type II Diabetic Muscles

Diabetes and Healthy Control | FTO Gene Expression | Aerobic Exercise Intervention or Home Exercise | Pre-training and Post-training

Taiwan
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Fixed Combination Therapy of Vildagliptin and Metformin (25/1000 mg Bid) in Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy (HbA1c 7.0-9.5%)

Diabetes Mellitus, Type 2

United States, Hungary, Poland, Germany, France
Novartis Pharmaceuticals

Completed

Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure

Type II Diabetes Mellitus | Congestive Heart Failure

Russian Federation, Singapore, Italy, Czechia, Lithuania, Germany, Guatemala, India, Denmark, Estonia, Slovakia, Romania, Latvia, Greece, Poland

Search clinical trials for: diabetes type II

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations